Turn Therapeutics Inc.(TTRX)
Biotechnology
Infectious Disease Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-12-12 | Chaudhary Zuraiz See Remarks | Purchase | +2,500 | +25.00%12,500 | $3.50 | $8,750 | View SEC filing | |
| 2025-11-25 | GOLDEN ARTHUR F Director | Purchase | +9,868 | +19.45%60,602 | $3.44 | $33,946 | View SEC filing | |
| 2025-11-24 | GOLDEN ARTHUR F Director | Purchase | +20,532 | +67.98%50,734 | $2.87 | $58,927 | View SEC filing | |
| 2025-11-21 | Chaudhary Zuraiz See Remarks | Purchase | +2,450 | +32.45%10,000 | $2.89 | $7,075 | View SEC filing | |
| 2025-11-17 | Chaudhary Zuraiz See Remarks | Purchase | +2,500 | +49.50%7,550 | $3.62 | $9,050 | View SEC filing | |
| 2025-10-29 | Chesed Abraham Other | Purchase | +14,286 | +1.00%1,447,268 | $4.60 | $65,716 | View SEC filing | |
| 2025-10-23 | Chaudhary Zuraiz See Remarks | Purchase | +5,050 | +100.00%5,050 | $4.95 | $24,998 | View SEC filing | |
| 2025-10-23 | GOLDEN ARTHUR F Director | Purchase | +20,202 | +202.02%30,202 | $4.95 | $100,000 | View SEC filing |
1-8 of 8